The Good Old Days: FDA's Jenkins Instructs Reviewers To Meet Original User Fee Review Time Standard
This article was originally published in The Pink Sheet Daily
Executive Summary
Office of New Drugs Director instructs FDA reviewers to return to the practice of meeting 90 percent of their review time goals for new drug applications.